Within the bladder cancer group, transitional cell carcinoma cases had enhanced gene expression of MAPK-3 compared to those with squamous cell carcinoma, and cases with high-grade malignancy varied significantly in gene expression of MAPK-3 compared to those with low-grade malignancy (Fig. 2). This evidence concerns the gene MAPK3 and urinary bladder cancer.